KERX
Keryx Biopharmaceuticals Inc
KERX
KERX
Delisted
KERX was delisted on the 12th of December, 2018.
129 hedge funds and large institutions have $363M invested in Keryx Biopharmaceuticals Inc in 2017 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 42 increasing their positions, 36 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less call options, than puts
Call options by funds: $ | Put options by funds: $
36% less capital invested
Capital invested by funds: $563M → $363M (-$201M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
129
Holding in Top 10
–
Calls
$3.96M
Puts
$5.98M
Top Buyers
| 1 | +$18.6M | |
| 2 | +$10.2M | |
| 3 | +$5.06M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$2.03M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.53M |
Top Sellers
| 1 | -$37.1M | |
| 2 | -$10.3M | |
| 3 | -$5.36M | |
| 4 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
-$5.33M |
| 5 |
MPAM
Monarch Partners Asset Management
Boston,
Massachusetts
|
-$4.87M |